MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) Files An 8-K Results of Operations and Financial Condition
Item 2.02: Results of Operations and Financial Condition.
Johnson) announced its financial results for the first quarter of
2017. A copy of the press release is furnished as Exhibit 99.1 to
this report and incorporated herein by reference.
|
99.1
|
Press Release of Mead Johnson Nutrition Company, dated
April 27, 2017 |
About MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN)
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe. MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) Recent Trading Information
MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) closed its last trading session down -0.02 at 88.78 with 2,656,831 shares trading hands.